Akèy › Neoplazmi myeloproliferatif › Oklahoma › Oklahoma City
Etid klinik pou Neoplazmi myeloproliferatif nan Oklahoma City, OK
4 etid pou Neoplazmi myeloproliferatif ap chèche patisipan nan sit nan ak bò kote Oklahoma City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Ap rekriteFaz 2
- University of Oklahoma Health Sciences Center, Oklahoma City
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
Ap rekriteFaz 2
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
- University of Oklahoma Health Sciences Center, Oklahoma City
Project: Every Child for Younger Patients With Cancer
Ap rekriteEtid obsèvasyon
- University of Oklahoma Health Sciences Center, Oklahoma City
Etid Neoplazmi myeloproliferatif nan lòt vil
- Houston, TX16 etid
- New York City, NY15 etid
- Boston, MA14 etid
- Milwaukee, WI10 etid
- Miami, FL10 etid
- Durham, NC9 etid
- Baldwin Park, CA9 etid
- Seattle, WA9 etid
- Chicago, IL9 etid
- Portland, OR8 etid
- Cleveland, OH8 etid
- Atlanta, GA8 etid
Lòt etid nan Oklahoma City
- Kansè Poumon ki pa ti selil28 etid
- Kansè ovè28 etid
- Kansè Endomèt25 etid
- Kansè kolorektal22 etid
- Kansè pwostat21 etid
- Kansè poumon19 etid
- Kansè nan tete17 etid
- Kansè Metastatik16 etid
- Kansè (tout kalite)14 etid
- Leksemi mieloïd egi14 etid
- Karsinòm selil skuamèz tèt ak kou13 etid
- Kansè vejik11 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.